Joachim Misselwitz
Overview
Explore the profile of Joachim Misselwitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
849
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Gool J, de Jong T, Winkler-Seinstra P, Tamminen-Mobius T, Lax H, Hirche H, et al.
Neurourol Urodyn
. 2013 Jun;
33(5):482-7.
PMID: 23775924
Objective: Functional urinary incontinence causes considerable morbidity in 8.4% of school-age children, mainly girls. To compare oxybutynin, placebo, and bladder training in overactive bladder (OAB), and cognitive treatment and pelvic...
2.
Schlingmann K, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al.
N Engl J Med
. 2011 Jun;
365(5):410-21.
PMID: 21675912
Background: Vitamin D supplementation for the prevention of rickets is one of the oldest and most effective prophylactic measures in medicine, having virtually eradicated rickets in North America. Given the...
3.
Seeman T, Pohl M, Misselwitz J, John U
Kidney Blood Press Res
. 2009 Dec;
32(6):440-4.
PMID: 20016211
Background/aims: Dual blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) has higher antiproteinuric effects than single blockade in adults. In children, little is...
4.
Offner G, Toenshoff B, Hocker B, Krauss M, Bulla M, Cochat P, et al.
Transplantation
. 2008 Nov;
86(9):1241-8.
PMID: 19005406
Background: Basiliximab, a monoclonal CD25 antibody has proofed effective in reducing acute rejection episodes in adults in various immunosuppressive regimens. The effect of basiliximab in the pediatric population is controversial....
5.
Baum A, Pohl M, Kreusch S, Cumme G, Ditze G, Misselwitz J, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2008 Oct;
876(1):31-40.
PMID: 18952508
Biomarker search using multidimensional native liquid fractionation of serum in microplates was evaluated. From different donors, homologous sample fractions with UV absorbance depending on state of illness were selected, and...
6.
Seeman T, Pohl M, John U, Dusek J, Vondrak K, Janda J, et al.
Kidney Blood Press Res
. 2008 Oct;
31(5):337-42.
PMID: 18946224
Background/aims: In adults, nighttime hypertension and hyperuricemia are new risk factors for progression of IgA nephropathy (IgAN). In children, nighttime blood pressure (BP) and serum uric acid have never been...
7.
Muscheites J, Wigger M, Drueckler E, Klaassen I, John U, Wygoda S, et al.
Pediatr Transplant
. 2008 Jun;
13(3):365-70.
PMID: 18537896
Acute rejection episodes following pediatric renal transplantation have been progressively reduced by recent immunosuppressive regimens. Nevertheless, grafts continue to fail over time and surrogate parameters for long-term RGS are lacking....
8.
Zurowska A, Feneberg R, Warady B, Zimmering M, Monteverde M, Testa S, et al.
Am J Kidney Dis
. 2008 Feb;
51(3):455-62.
PMID: 18295061
Background: The proportion of gram-negative causative organisms in peritoneal dialysis-associated peritonitis is increasing. Little published information for this complication exists in children. The objective of this study is to evaluate...
9.
Martinez-Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, et al.
J Am Soc Nephrol
. 2008 Feb;
19(3):639-46.
PMID: 18235085
Mutations in the gene encoding complement factor H (CFH) that alter the C3b/polyanions-binding site in the C-terminal region impair the capacity of factor H to protect host cells. These mutations...
10.
Jungraithmayr T, Wiesmayr S, Staskewitz A, Kirste G, Bulla M, Fehrenbach H, et al.
Transplantation
. 2007 Apr;
83(7):900-5.
PMID: 17460560
Background: Mycophenolate mofetil (MMF) based immunosuppression after renal transplantation has proven to be safe and beneficial for children and adolescents. However, long-term analysis, in particular of pediatric patients, is scarce....